People researching lithium vs Lamictal usually want a winner, and the evidence does not crown one. Lithium and Lamictal (lamotrigine) are both used to prevent mood episodes in bipolar disorder, and they differ in ways that matter: which pole of the illness each protects against best, how much monitoring each requires, and what risks each carries. Those differences, not a ranking, are what actually decide which one a psychiatrist reaches for. This comparison walks through how each medication works, what the research shows, their side effects and safety considerations, and the questions that shape the choice, including pregnancy planning and whether the two can be combined.
How Each Medication Works and What It Is Approved For
Lithium is the oldest mood stabilizer in psychiatry and still one of its most effective tools. It is used to treat acute manic episodes and as maintenance treatment, meaning ongoing medication that lowers the risk of future episodes.
Lamotrigine, sold as Lamictal, came to psychiatry from epilepsy treatment. It is an anticonvulsant, and its FDA approval in bipolar disorder covers maintenance treatment of bipolar I disorder, to delay the time to new mood episodes. It is not approved for treating acute mania, which means a person in the middle of a manic episode needs something else. In practice, lamotrigine's role is prevention, and clinicians most often think of it in connection with the depressive side of the illness.
Lithium vs Lamictal: Side-by-Side
What the Research Shows
The cleanest head-to-head data comes from an 18-month placebo-controlled trial in people with bipolar I disorder who had recently been depressed, with 463 patients randomized to lamotrigine, lithium, or placebo (Calabrese et al., Journal of Clinical Psychiatry, 2003). Lamotrigine beat placebo at delaying depressive episodes: at one year, 57% of people on lamotrigine had needed no intervention for depression, compared with 45% on placebo. Lithium beat placebo at delaying manic and hypomanic episodes, with 86% intervention-free for mania at one year versus 72% on placebo.
A 2021 Cochrane review pooling 11 trials and 2,314 participants filled in the comparison between the two drugs (summarized in American Family Physician, 2022). Lamotrigine and lithium had similar rates of depressive recurrence. Lamotrigine was less effective than lithium at reducing manic recurrence at one year. And fewer people on lamotrigine reported side effects than people on lithium over 6 to 12 months, a practical signal about tolerability.
You will often see this compressed into a slogan: Lamictal for depression, lithium for mania. The slogan is directionally useful and too simple. Lamotrigine's depressive-prevention results were similar to lithium's in the Cochrane data, and the absolute differences in the Calabrese trial were modest. Episode history, side effects, and monitoring preferences do more work in the real decision than the slogan suggests.
Monitoring and Safety
Lithium's prescribing information builds monitoring into the treatment: regular serum level checks, because the gap between a helpful and a harmful level is narrow, plus periodic kidney and thyroid testing, since the label identifies both as organs lithium can affect. For many people this becomes an unremarkable part of the routine, a few blood draws a year once stable. It is a real commitment, and a manageable one.
Lamotrigine does not require routine blood level monitoring, which is one of its practical appeals. Its defining safety issue is different: an FDA boxed warning for serious skin rashes, including Stevens-Johnson syndrome. Per the label, serious rash is rare, nearly all cases appear in the first 2 to 8 weeks of treatment, and the slow dose escalation the label requires exists to reduce that risk. This is why lamotrigine cannot be started quickly, and why any new rash during those early weeks should be reported to the prescriber right away. Neither safety profile is a reason for alarm. Both are reasons the medication belongs under a psychiatrist's supervision.
Side Effects Compared
The side effects most commonly reported with lithium in its labeling and the clinical literature are tremor, increased thirst and urination, weight gain, and thyroid effects, usually an underactive thyroid that is itself treatable. Lamotrigine is generally described as weight-neutral in the literature, with headache, dizziness, and nausea its commonly reported side effects, along with the rash risk described above. For someone whose previous medication caused significant weight gain, that difference alone can shape the conversation. For someone whose illness leans heavily manic, lithium's strength against that pole can outweigh its side-effect burden.
Suicide Risk and Lithium: What Is and Is Not Established
Lithium is frequently described as the mood stabilizer that prevents suicide, and the research record deserves more precision than that. A 2013 meta-analysis in The BMJ (Cipriani et al.) reported fewer suicides among people taking lithium than among controls. A 2022 reanalysis in Epidemiology and Psychiatric Sciences (Nabi et al.) reached a different conclusion: restricted to randomized trials, the evidence is inconclusive, because suicide is rare and a handful of events drive the estimates. Researchers are actively debating which analysis handles the data better. Lithium may protect against suicide, but the randomized evidence can't yet confirm it, so the question remains open.
Pregnancy and Planning Ahead
Lithium and lamotrigine carry different considerations in pregnancy, and this is a planning conversation rather than a verdict. For anyone who could become pregnant, the time to discuss medication is before conception, with a psychiatrist who can weigh episode history against the specific risks and benefits of each option, sometimes alongside an obstetrician. Untreated bipolar disorder in pregnancy carries its own serious risks, so the goal of that conversation is a plan that protects both the pregnancy and the person's stability, not a reflexive stop.
Can Lithium and Lamictal Be Used Together?
Yes, and the combination is common in clinical practice. The usual logic pairs lithium's protection against manic episodes with lamotrigine's role on the depressive side. Whether that combination fits any individual person is a psychiatrist's call, made from their episode pattern, their response history, and how they tolerate each medication.
Talking to a Psychiatrist About the Right Fit
The lithium vs lamotrigine decision runs through a short list of personal questions. Which pole of the illness has dominated your history, mania or depression? How do you feel about regular blood tests? Which side-effect profile is more livable for you? Are pregnancy plans on the horizon? A psychiatrist who knows your full history turns those answers into a plan, and adjusts it as your life and your illness change. Medication changes should never be self-directed, including stopping a drug that seems to have done its job.
Bipolar disorder treatment at Amae Health pairs that medication expertise with therapy and whole-person support in one coordinated care model, built for people whose illness has been hard to stabilize. If you are weighing these medications, or your current one is not working, talk with an Amae psychiatrist about what fits your history. Our guide to effective bipolar disorder treatment covers the bigger picture beyond medication.
Frequently Asked Questions
Is lithium or Lamictal better for bipolar depression?
Neither is simply better. Lamotrigine is often used to prevent depressive episodes, and in the 2021 Cochrane review its depressive-recurrence results were similar to lithium's. The right choice depends on a person's episode pattern, side-effect tolerance, and history, judged by their psychiatrist.
Is Lamictal effective for mania?
It is not approved for treating acute mania, and in the Cochrane review it was less effective than lithium at preventing manic recurrence at one year. People whose illness runs manic usually need a different or additional medication.
Do I need blood tests on Lamictal?
Routine blood level monitoring is not typically required for lamotrigine, unlike lithium. A clinician still tracks response and side effects, especially during the first weeks.
Why does Lamictal have to be started so slowly?
Slow dose escalation lowers the risk of serious skin rash, the subject of the medication's FDA boxed warning. Nearly all serious rashes occur in the first 2 to 8 weeks, so any rash in that window should be reported promptly.
Does lithium cause weight gain?
For some people, yes. Weight gain is a recognized lithium side effect, alongside tremor, thirst, and thyroid changes, while lamotrigine is generally considered weight-neutral. Individual experience varies widely.
Can you take lithium and Lamictal together?
Yes, the combination is common in clinical practice, often pairing lithium's anti-manic protection with lamotrigine's depressive-side coverage. It is a decision for you and your psychiatrist, never a self-directed change.
What if I am having thoughts of suicide?
The 988 Suicide and Crisis Lifeline offers free, confidential support by call or text, 24/7. If you are in immediate danger, call 911 or go to the nearest emergency room.
Citations
- Calabrese JR, Bowden CL, Sachs G, et al. "A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder." Journal of Clinical Psychiatry, 2003;64(9):1013-1024. psychiatrist.com. Tier 1 (peer-reviewed RCT).
- Hashimoto Y, et al. Cochrane review (2021) on lamotrigine for bipolar maintenance, summarized in American Family Physician, 2022. aafp.org. Tier 1 (Cochrane systematic review).
- Cipriani A, Hawton K, Stockton S, Geddes JR. "Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis." BMJ, 2013;346:f3646. Tier 1 (peer-reviewed meta-analysis).
- Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J. "Effects of lithium on suicide and suicidal behaviour: a systematic review and meta-analysis of randomised trials." Epidemiology and Psychiatric Sciences, 2022;31:e65. Tier 1 (peer-reviewed meta-analysis).
- 988 Suicide and Crisis Lifeline. 988lifeline.org. Tier 2 (FAQ only).
